Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Doripenem Versus Meropenem As the First-Line Mono-Therapy in High-Risk Febrile Neutropenic Patients with Acute Leukemia: A Randomized, Controlled Trial

Tatsuo Oyake, Norifumi Sugawara, MD, PhD, Shinri Miyajima, MD, Kazuki Kiyohara, MD, Maki Nishiya, MD PhD, Tadashi Shimoyama, MD PhD, Yuka Takemasa-Fujisawa, MD PhD, Ryosei Sasaki, MD PhD, Wataru Izumita, MD, Yasuhiko Tsukushi, MD, PhD, Akihiro Otsu, MD, PhD, Takahiro Mine, MD, Takeshi Sugawara, MD, Yuzo Suzuki, MD PhD, Yoshiaki Okano, MD, PhD, Ichiro Hanamura, MD PhD, Shugo Kowata, MD, PhD, Shigeki Ito, MD, PhD

Blood (2019) 134 (Supplement_1): 4865.

https://doi.org/10.1182/blood-2019-131305

Published: 2019

Journal Articles

The First Case Report of Tazobactam Induced Thrombocytopenia

Minh-Tri H. Nguyen, MD, Pavneet Kaur, MD, Richard H. Aster, MD, Vidya Krishnan, MD MHS

Blood (2019) 134 (Supplement_1): 4897.

https://doi.org/10.1182/blood-2019-126227

Published: 2019

Journal Articles

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Matthew John Slaught, BS, Daniel W. Bougie, PhD, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 2350.

https://doi.org/10.1182/blood-2019-131375

Published: 2019

Journal Articles

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Mark Rasmussen, Daniel W. Bougie, PhD, Gregory H. Denomme, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 1078.

https://doi.org/10.1182/blood-2019-130966

Published: 2019

Journal Articles

Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Marshall McKenna, MD, Rena Feinman, PhD, Jaeil Ahn, PhD, Shuqi Wang, MSc, Elli Gourna Paleoudis, PhD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, Jun Chih Wang, MD, Abdul Rehman, MD, Giselle Alexandra Suero-Abreu, MD PhD, Phyllis McKiernan, Michele L. Donato, MD, Scott D. Rowley, MD, David S. Siegel, Noa Biran, MD

Blood (2019) 134 (Supplement_1): 5510.

https://doi.org/10.1182/blood-2019-132134

Published: 2019

Journal Articles

Bolus Versus Prolonged Infusion of Broad-Spectrum Beta-Lactams for Patients with Hematologic Malignancies and High Risk Febrile Neutropenia - a Single Center Prospective Unblinded Randomized Trial

Ron Ram, MD, Irit Avivi, MD, Odelia Amit, BSc, Yael Halavy, Yael Paran, MD, Eugene Katchman, Bruria Yachini, RN, Kor Svetlana, RN, Ronen Ben Ami, MD

Blood (2017) 130 (Supplement 1): 282.

https://doi.org/10.1182/blood.V130.Suppl_1.282.282

Published: 2017

Journal Articles

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Luna Osakabe, DDS, Bungo Saito, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Akemi Utsumi, DDS, Kunihiko Fukuchi, MD, Tsuyoshi Nakamaki, MD, Shouji Hironaka, DDS

Blood (2016) 128 (22): 5752.

https://doi.org/10.1182/blood.V128.22.5752.5752

Published: 2016

Journal Articles

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Yasunori Nakagawa, MD, PhD, Takahiro Mine, MD, Ichiro Hanamura, MD, PhD, Maki Asahi, MD, Yukiteru Fujishima, MD, Yusei Aoki, MD, Shugo Kowata, MD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD

Blood (2014) 124 (21): 4954.

https://doi.org/10.1182/blood.V124.21.4954.4954

Published: 2014

Journal Articles

Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies

Katsuhiro Miura, MD, Satomi Kiso, MD, Masaru Nakagawa, MD, Hiromichi Takahashi, MD PhD, Yoshito Uchino, MD, Hitomi Kodaira, MD, Noriyoshi Iriyama, MD PhD, Masashi Sakagami, MD, Shimon Ohtake, MD, Sumiko Kobayashi, MD PhD, Atsuko Hojo, MD, Mai Yagi, MD, Daisuke Kurita, MD, Yujin Kobayashi, MD PhD, Machiko Kusuda, MD, Yukio Hirabayashi, MD PhD, Yoshihiro Hatta, MD PhD, Masami Takei, MD PhD

Blood (2014) 124 (21): 3674.

https://doi.org/10.1182/blood.V124.21.3674.3674

Published: 2014

Journal Articles

Outcome Of Escherichia Coli (E.coli) Blood Stream Infections (BSI) In Haematology-Oncology Patients- Hematopoetic Stem Cell Transplantation (HSCT) Is Not Associated With Increased Mortality

Zena Salih, MRCP, Felicity Fergusson, MRCP, Andrew Stevens, MBBS, Katalina Balassa, MD, Theingi Yin, MRCP, Kirsty Dodgson, FRCPath, Kaczmarsky Ed, FRCPath, Malcolm Guiver, PhD, Ken Mutton, FRCPath, Mike Dennis, FRCPath, Jim Cavet, FRCPath, Tim Sommervaile, FRCPath, Jo Tomlins, RGN, BN, MSc,, John Murray, RGN, MSc, Adrian Bloor, PhD, FRCP, FRCPath, Samar Kulkarni, MD, MRCP, FRCPath

Blood (2013) 122 (21): 5455.

https://doi.org/10.1182/blood.V122.21.5455.5455

Published: 2013

Journal Articles

Doripenem Versus Meropenem For Empirical Antimicrobial Therapy In High Risk Febrile Neutropenic Patients With Hematological Malignancies: A Randomized, Controlled Trial

Yuka Fujisawa, M.D., Tatsuo Oyake, M.D., Ph.D., Takahiro Mine, M.D., Yusei Aoki, M.D., Yasuhiko Tsukushi, M.D., Ph.D., Takeshi Sugawara, M.D., Masato Seguchi, M.D., Ph.D., Ichiro Hanamura, M.D., Ph.D., Yasuaki Nakagawa, M.D., Ph.D., Kazunori Murai, M.D., Ph.D., Shigeki Ito, M.D., Ph.D., Yoji Ishida, M.D., Ph.D.

Blood (2013) 122 (21): 4716.

https://doi.org/10.1182/blood.V122.21.4716.4716

Published: 2013

Journal Articles

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Takahiko Nakane, MD, PhD, Toshiharu Tamaki, Kazuo Tamura, MD, PhD, Isao Yoshida, MD, Toshihiro Fukushima, MD, PhD, Yoichi Tatsumi, MD, PhD, Yasunori Nakagawa, MD, Kazuo Hatanaka, MD, Tsutomu Takahashi, MD, PhD, Nobu Akiyama, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuma Ohyashiki, MD, PhD, Akio Urabe, MD, PhD, Tohru Masaoka, MD, PhD, Akihisa Kanamaru, MD, PhD

Blood (2012) 120 (21): 1037.

https://doi.org/10.1182/blood.V120.21.1037.1037

Published: 2012

Journal Articles

Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States

Marko Kavcic, MD, Brian T. Fisher, DO, MSCE, Yimei Li, PhD, Alix E. Seif, MD, MPH, Kari Torp, Yuan-Shung Huang, MS, Grace E. Lee, MD, Sarah K Tasian, MD, Ami V. Desai, MD, Marijana Vujkovic, PhD, Rochelle Bagatell, MD, Richard Aplenc, MD, PhD

Blood (2012) 120 (21): 4283.

https://doi.org/10.1182/blood.V120.21.4283.4283

Published: 2012

Journal Articles

Infections with Multi-Drug Resistant Gram-Negative Pathogens in Patients Receiving Treatment for Hematological Malignancies: Risk Factors and Outcomes.

Hong Yen Ng, B.Sc(Pharm)(Hons), BCOP, Gee Chuan Wong, MBBS, MRCP, FRCP, Vin Cci Ng, B.Sc(Pharm)(Hons), Mun Yee Tham, B.Sc(Pharm)(Hons), Rachel Ong, B.Sc(Pharm)(Hons), Ching Hui Lim, B.Sc(Pharm), BCOP

Blood (2008) 112 (11): 1472.

https://doi.org/10.1182/blood.V112.11.1472.1472

Published: 2008

Journal Articles

Epidemiology, Risk Factors and Outcome of 282 Bloodstream Infections among Hematological Patients: Results of a 50 Months Prospective Surveillance Study

Chiara Cattaneo, Francesca Bracchi, Salvatore Casari, Erika Borlenghi, Maria Adele Capucci, Anna Maria Pelizzari, Liana Signorini, Massimiliano De Vecchi, Monica Drera, Alessandro Re, Giampiero Carosi, Giuseppe Rossi

Blood (2008) 112 (11): 4835.

https://doi.org/10.1182/blood.V112.11.4835.4835

Published: 2008

Journal Articles

Piperacillin Induced Thrombocytopenia in Critical Care Patients as Compared to Non Critical Patients.

Seema Naik, MD, Ashish Sangal, MD, Srinivas Kodali, MD, Theresa Dumlao, MD, Madhumati Kalavar, MD, William Steier, MD, Zili He

Blood (2007) 110 (11): 3916.

https://doi.org/10.1182/blood.V110.11.3916.3916

Published: 2007

Journal Articles

Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin

SF Burroughs, GJ Johnson

Blood (1990) 75 (7): 1473–1480.

https://doi.org/10.1182/blood.V75.7.1473.1473

Published: 1990

NARROW

Doripenem Versus Meropenem As the First-Line Mono-Therapy in High-Risk Febrile Neutropenic Patients with Acute Leukemia: A Randomized, Controlled Trial

The First Case Report of Tazobactam Induced Thrombocytopenia

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Bolus Versus Prolonged Infusion of Broad-Spectrum Beta-Lactams for Patients with Hematologic Malignancies and High Risk Febrile Neutropenia - a Single Center Prospective Unblinded Randomized Trial

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies

Outcome Of Escherichia Coli (E.coli) Blood Stream Infections (BSI) In Haematology-Oncology Patients- Hematopoetic Stem Cell Transplantation (HSCT) Is Not Associated With Increased Mortality

Doripenem Versus Meropenem For Empirical Antimicrobial Therapy In High Risk Febrile Neutropenic Patients With Hematological Malignancies: A Randomized, Controlled Trial

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States

Infections with Multi-Drug Resistant Gram-Negative Pathogens in Patients Receiving Treatment for Hematological Malignancies: Risk Factors and Outcomes.

Epidemiology, Risk Factors and Outcome of 282 Bloodstream Infections among Hematological Patients: Results of a 50 Months Prospective Surveillance Study

Piperacillin Induced Thrombocytopenia in Critical Care Patients as Compared to Non Critical Patients.

Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only